Final Program as PDF documents: General Program | Friday | Saturday | Sunday

• Preventing HIV: Options Beyond Vaccines
  Mayer Kenneth, USA
• Expanding ARV Therapy in Limited Resource Settings
  de Avila Vitoria Marco Antonio, SWITZERLAND 
• Managing ARV Therapy: When to Start, When to Change?
  Cahn Pedro, ARGENTINA
• New Treatment Options on the Horizon
  (speaker to be confirmed)

• Rabbits, Hares and People: Tularemia on the Iberian Peninsula
  Eiros Jose, SPAIN
• Brucellosis
  Ariza Javier, SPAIN
• Q Fever
  de Alarcon Aristides, SPAIN
• Update on Echinococcosis
  Brunetti Enrico, ITALY

• Update on Conjugate Pneumococcal Vaccine Effect on Invasive Disease - Pneumonia and Herd Immunity
  Klugman Keith, USA
• The Replacement Phenomenon in Pneumococcal Conjugate Vaccines (PCV) - What are the Implications?
  Dagan Ron, ISRAEL
• Pneumococcal Protein-based Vaccines: The Next-Generation Pneumococcal Vaccines?
  Mitchell Tim, SCOTLAND, UK
• Global Pediatric Pneumococcal Vaccination Implementation: Where Are We in 2006?
  O'Brien Kate, USA

• Burden of Herpes Zoster and Post-Herpetic Neuralgia in Europe
  Pedalino Biagio, FRANCE 
• Herpes Zoster: A Severe Disease
  McElhaney Janet, CANADA
• A Vaccine to Prevent Herpes Zoster and PHN: An Answer to an Unmet Need
  Johnson Robert, UNITED KINGDOM

• The Role of Atypical Bacteria in URTI
  Esposito Susana, ITALY
• The Role of Atypical Bacteria in LRTI
  Amsden Guy, USA
• Intracellular Pharmacokinetics of Azithromycin
  Krcmery Vladimir, SLOVAKIA
• Position of Modern Macrolides in International CAP Guidelines
  Lode Hartmut, GERMANY

• Using the Clinical Laboratory to Limit Hospital Antibiotic Resistance
  Rossi Flavia, BRAZIL
• Anti-Fungal Resistance Testing: When is it Needed to Improve Care?
  Moretti Maria Luiza, BRAZIL
• DNA Chips in Clinical Microbiology
  van Eldere Johan, BELGIUM
• Comparative Genomics: Is It of Any Clinical Use?
  Raoult Didier, FRANCE

• Quality Improvement in Infection Control in Resource-limited Setting
  Memish Ziad, SAUDI ARABIA
• Surveillance for the Detection and Control of Multiple Drug-resistant Nosocomial Pathogens in the Middle East
  Shibl Atef, SAUDI ARABIA
• Establishing Effective Control Programs for Surgical Site Infections
  Eremin Sergei, RUSSIA
• Dealing with Formidable and Novel Pathogens in Minimally-resourced Settings
  Duse Adriano, SOUTH AFRICA

• Do PD/PK Parameters Predict Emerging Resistance?
  Low Donald, CANADA
• New Antibiotics and New Antibiotic-resistance Mechanisms in Pneumococci
  Farrell David, UNITED KINGDOM
• What Have We Learned from Trends in Antibiotic Resistance After Introduction of PCVs?
  Klugman Keith, USA
• Do Interventions in Antibiotic Use Influence Antibiotic-resistant S. pneumoniae?
  Dagan Ron, ISRAEL

• Cervical Cancer and Earlier HPV Related Lesions in my Gynecology Clinic and in the World
  Paavonen Jorma, FINLAND
• An Overview of the Clinical Development and Results of a Quadrivalent HPV Vaccine
  Villa Luisa, BRAZIL
• Natural and Vaccine Induced Immunity to Human Papillomavirus Infection
  Frazer Ian, AUSTRALIA
• Audience response ­ Programmatic Issues for Cervical Cancer and HPV Vaccination:
  - Age of Vaccination
  - Universal Vaccination and Genders
  - Parent and Vaccinees’ Acceptability
  - Complementary to Screening
  Moderators: Reisinger Keith, USA & Ault Kevin, USA

• The Molecular Virology of the 1918 Influenza and Its Implications for the Next Pandemic
  Taubenberger Jeffery, USA
• Pandemic Influenza Preparedness at the National and International Level
  Fukuda Keiji, SWITZERLAND
• Pandemic Influenza: Vaccine Development and Other Approaches to Prevention and Treatment
  Fedson David, FRANCE
• Stark Political Decisions Ahead: Persuading Leaders to Make the Right Choices on Pandemic Influenza
  Inglesby Thomas, USA

• The FACT Project - An Original Initiative: Concepts, Strategies and Some Results
  Kiechel Jean-René, SWITZERLAND
• Pharmacokinetics of Artesunate Derivatives - Studies in Volunteers with the New Fixed-dose Combinations
  Navaratnam Visweswaran, MALAYSIA
• The FACT Project: Development of a Fixed Combination of Artesunate and Mefloquine
  Ashley Elizabeth, THAILAND
• Field Study with Artesunate + Amodiaquine (AS+AQ) in Burkina Faso
  Sirima Sodiomon B., BURKINA FASO
• Artesunate + Amodiaquine (AS+AQ) for the Treatment of Uncomplicated falciparum Malaria: An Inventory and Systematic Review of Safety and Efficacy Data. Preliminary Findings
  Olliaro Piero, SWITZERLAND

• Diagnosing Fungal Infections: What Test Strategies Improve Outcomes?
  Verweij Paul, NETHERLANDS
• Fungal Infections in the ICU: When and What Empiric Therapy?
  Wolff Michel, FRANCE
• Pro: Is Combination Anti-Fungal Therapy The New Standard for Invasive Fungal Infections?
  Gavalda Joan, SPAIN
• Con: Is Combination Anti-Fungal Therapy The New Standard for Invasive Fungal Infections?
  Graybill John, USA

• Genetic Evolution of Mycobacterium tuberculosis: Stable Association Between Strains and Human Host Populations
  Tsolaki Anthony, UNITED KINGDOM
• Immune-based diagnosis of Tuberculosis: Options for High and Low Resource Areas
  Weldingh Karin, DENMARK
• Tuberculosis Drug Development: Where Are We in 2006?
  Ginsberg Ann, USA
• Tuberculosis Control Beyond DOTS: What Do We Need?
  Godfrey-Faussett Peter, UNITED KINGDOM

• The Need for a Pediatric Quadrivalent Vaccine for Measles, Mumps, Rubella and Varicella in Europe
  Ramet Jose, BELGIUM
• Case Study ­ Germany ­ Epidemiology for Varicella and Health Economics of Vaccination
  Wutzler Peter, GERMANY
• Overview of the Safety & Immunogenicity of MMRV Vaccine
  Reisinger Keith, USA
• Pentavalent Rotavirus Vaccine - A New Strategy
  Offit Paul, USA
• The Efficacy of a Pentavalent Rotavirus Vaccine on Urgent Care Outcomes from 11 Countries
  Vesikari Timo, FINLAND
• An Update on the Safety Profile of Pentavalent Rotavirus Vaccine from the REST Study
  Dennehy Penelope, USA

• Pediatric Preventive HIV Vaccines
  Luzuriaga Katherine, USA
• Protecting Mothers and Children: HIV Mother-to-Child Transmission (MTCT) in Low-Resource Settings
  Dabis Francois, FRANCE
• Treatment of Pediatric HIV: State-of-the-Art in 2006
  Giaquinto Carlo, ITALY
• Optimizing Pediatric HIV Treatment in Low-resource Settings
  Chokephaibulkit Kulkanya, THAILAND

• The Mismatch between Current Medical Needs and the Antimicrobial Development Pipeline: A Public Health Crisis in the Making
  Talbot George, USA
• The European Response to the Technology Gap
  Finch Roger, UNITED KINGDOM
• Clinical Research in Latin America. Development of New Antimicrobials and Vaccines
  Gotuzzo Eduardo, PERU
• New Public Health Threats - The Role of the ECDC
  Ozin Amanda, SWEDEN 

• Treatment of Tuberculosis in HIV-infected Patients
  Amaral Leonard, PORTUGAL
• Treatment of Latent Tuberculosis Infection in HIV-infected Patients
  Moreno Santiago, SPAIN
• Strategies to Improve Patient Adherence to Tuberculosis Treatment
  Knobel Hernando, SPAIN
• Infection Control and Treatment of Latent Infection in Patients with Multidrug-resistant Tuberculosis
  Valadas Emilia, PORTUGAL

• Plague and Black Death
  Drancourt Michel, FRANCE
• Characterization of the 1918 'Spanish' Influenza Virus
  Taubenberger Jeffery, USA
• Mycobacterium Disease at the Origins of Urban Life in Egypt
  Crubezy Eric, FRANCE
• Human Louse Infestations: Past and Present
  Mumcuoglu Kosta, ISRAEL
• Phylogenetic Analysis of the tprC, D, I, K, G, and J Genes in the Genus Treponema and Implications for Evolution of the Human Treponemes
  Mulligan Connie, USA

• Epidemiology of Pneumococcal Disease and Efficacy of Polysaccharide Vaccines in Adults
  Ohl Christopher, USA
• Immunogenicity after Revaccination with Polysaccharide Vaccine
  Manhoff Susan, USA
• Institutional Protocols and Adult Vaccination
  Zimmerman Richard, USA
• Outcomes of Vaccination in Adults with Polysaccharide Vaccine
  Mooney John D., UNITED KINGDOM

• Clonal Epidemiology Worldwide
  Etienne Jerome, FRANCE
• Prevalence and Risk Factors
  Linde Hans-Joerg, GERMANY
• Treatment Options for Community-acquired Staphylococcal Infections: End of Beta-Lactam Era?
  Cercenado Emilia, SPAIN
• Control Strategies
  Turnidge John, AUSTRALIA

• Avian Influenza - An Emerging Threat
  Capua Ilaria, ITALY
• OIE System for Notification and Surveillance of Animal Diseases and Zoonoses
  Ben Jebara Karim, FRANCE
• Contribution of Other International and Non-Governmental Organizations Involved
  Shimshony Arnon, ISRAEL
• Investigating the Role of Animals in the Origin of Zoonotic Emergencies
  Manuguerra Jean-Claude, FRANCE
• Early Detection and Rapid Response: An International Public Good
  Vallat Bernard, FRANCE

• HIV/AIDS Caregiving and Gender at the Center of the Pandemic
  Heymann Sally, CANADA
• Women as High-Risk Victims of Infection
  Temmerman Marleen, BELGIUM
• Women as Leaders in the Effort to Control Infections
  Mehtar Shaheen, SOUTH AFRICA
• The Relation Between Women's Rights and Infectious Diseases
  Himmich Hakima, MOROCCO

• Innate Immunity: Friend or Foe?
  Golenbock Douglas, USA
• Are All Hosts Equal? Does Genetics Matter?
  Mira Jean-Paul, FRANCE
• Antibiotic Therapy in Sepsis: A Forgotten Art
  Cohen Jon, UNITED KINGDOM
• Steroids Good or Bad - A Critical Appraisal
  Sprung Charles, ISRAEL

• Infections and Asthma: Understanding the Relationships
  Matricardi Paolo, GERMANY
• Tuberculosis: Recognition and Management in Children With and Without HIV
  Madhi Shabir, SOUTH AFRICA
• Pertussis: Increasing Old Problem
  Mertsola Jussi, FINLAND
• Measles in Sudan: Towards Mortality Reduction and Regional Elimination
  Ibrahim Salah, SUDAN
• Pediatric Influenza
  Weil-Olivier Catherine, FRANCE

• Cell-mediated Immunity: Challenges for Developing Effective Vaccines
  Liljestrom Peter, SWEDEN
• Update on Malaria Vaccines: In the Field and the Laboratory
  Hill Adrian, UNITED KINGDOM
• Tuberculosis Vaccines: Ready for Prime Time?
  Reed Steve, USA
• The Bumpy Road to an AIDS Vaccine
  Johnston Margaret, USA

• Present and Future of Rotavirus Vaccines
  O'Ryan Miguel, CHILE
• Hepatitis A: Experiences with Universal Immunization
  Mcintosh Ken, USA
• Polio: Defining the Optimal Vaccine Strategy
  Aylward Bruce, SWITZERLAND
• Vaccination for Premature Infants: What Vaccines When?
  Odio Carla, COSTA RICA

• Worldwide MRSA Spread: Bridges Between Molecular Biology and Healthcare
  de Lencastre Herminia, PORTUGAL
• Evidence: What Works, What does not Work for MRSA Control?
  Stone Sheldon, UNITED KINGDOM
• Successful Control of Endemic MRSA: Is it Possible?
  Lucet Jean-Christophe, FRANCE
• Rapid Screening for MRSA: Myth or Reality?
  Schrenzel Jacques, SWITZERLAND

• How PD/PK Characteristics and Resistance Affect Treatment Strategies
  White Nicholas, THAILAND
• Assessing Treatment Efficacy in Vivo: What Should We Follow?
  Plowe Christopher, USA
• Treating Malaria During Pregnancy: Facing the Challenge with Limited Options
  Mutabingwa Theonest, TANZANIA
• New Antimalarial Agents and New Therapeutic Combinations
  Ashley Elizabeth, THAILAND

• Epidemiology and Natural History of HIV-HCV Coinfection
  Pineda Juan Antonio, SPAIN
• HCV and Risk of Hepatotoxicity with HAART
  Mansinho Kamal, PORTUGAL
• Therapeutic Regimens for Hepatitis C in HIV-infected Patients
  Sarmento e Castro Rui, PORTUGAL
• Liver Transplantation In HIV-infected Patients: Update in 2006
  Miró José M., SPAIN